These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10069924)

  • 1. The US Food and Drug Administration investigational device exemptions (IDE) and clinical investigation of cardiovascular devices: information for the investigator.
    Pritchard WF; Abel DB; Karanian JW
    J Vasc Surg; 1999 Mar; 29(3):566-74. PubMed ID: 10069924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The US Food and Drug Administration investigational device exemptions and clinical investigation of cardiovascular devices: information for the investigator.
    Pritchard WF; Abel DB; Karanian JW
    J Vasc Interv Radiol; 1999 Feb; 10(2 Pt 1):115-22. PubMed ID: 10082096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding Food and Drug Administration regulatory requirements for an investigational device exemption for sponsor-investigators.
    Holbein ME; Berglund JP
    J Investig Med; 2012 Oct; 60(7):987-94. PubMed ID: 22847340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical devices; investigational device exemptions--FDA. Final rule.
    Fed Regist; 1998 Nov; 63(225):64617-26. PubMed ID: 10338870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical devices; investigational device exemptions--FDA. Proposed rule.
    Fed Regist; 1998 Jul; 63(135):38131-8. PubMed ID: 10181246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The US Food and Drug Administration 515 Program Initiative: Addressing the Evidence Gap for Widely Used, High-Risk Cardiovascular Devices?
    Rathi VK; Kesselheim AS; Ross JS
    JAMA Cardiol; 2016 May; 1(2):117-8. PubMed ID: 27437879
    [No Abstract]   [Full Text] [Related]  

  • 7. Medical devices; reclassification of six cardiovascular preamendments class III devices into class II. Final rule.
    Food and Drug Administration
    Fed Regist; 2001 Apr; 66(69):18540-2. PubMed ID: 11721689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performing clinical studies involving hernia mesh devices: what every investigator should know about the FDA investigational device exemption (IDE) process.
    Ashar BS; Dang JM; Krause D; Luke MC
    Hernia; 2011 Dec; 15(6):603-5. PubMed ID: 21909977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marketing approval for the lithotripter.
    Nightingale SL; Young FE
    Isr J Med Sci; 1986; 22(7-8):519-23. PubMed ID: 3781809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDA's perspectives on cardiovascular devices.
    Chen EA; Patel-Raman SM; O'Callaghan K; Hillebrenner MG
    J Cardiovasc Transl Res; 2009 Jun; 2(2):143-6. PubMed ID: 20559979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical devices; procedures for investigational device exemptions--Food and Drug Administration. Final rule.
    Fed Regist; 1980 Jan; 45(13):3732-59. PubMed ID: 10248822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA regulation of dental devices: past, present, and future.
    Tylenda CA
    J Public Health Dent; 1992; 52(6):364-8. PubMed ID: 1432925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Food and Drug Administration's Perspective on Medical Devices Intended for Weight Loss: A Guide for the Interventional Radiologist.
    Marrone AK
    Tech Vasc Interv Radiol; 2020 Mar; 23(1):100661. PubMed ID: 32192636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical devices: US medical device regulation.
    Jarow JP; Baxley JH
    Urol Oncol; 2015 Mar; 33(3):128-32. PubMed ID: 25458071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicare program; criteria and procedures for extending coverage to certain devices and related services--HCFA. Final rule with comment period.
    Fed Regist; 1995 Sep; 60(181):48417-25. PubMed ID: 10151184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of Food and Drug Administration regulation of drugs, biologics, and devices to be used for management of periodontal diseases.
    Tylenda CA; Weintraub M
    Ann Periodontol; 1997 Mar; 2(1):11-7. PubMed ID: 9151539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An introduction to the Food and Drug Administration and how it evaluates new devices: establishing safety and efficacy.
    Wholey MH; Haller JD
    Cardiovasc Intervent Radiol; 1995; 18(2):72-6. PubMed ID: 7773998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular and neurological devices; reclassification of two embolization devices. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Dec; 69(249):77898-900. PubMed ID: 15624254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical Device Classification Procedures: Incorporating Food and Drug Administration Safety and Innovation Act Procedures. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2018 Dec; 83(241):64443-58. PubMed ID: 30557920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicare covers the majority of FDA-approved devices and Part B drugs, but restrictions and discrepancies remain.
    Chambers JD; May KE; Neumann PJ
    Health Aff (Millwood); 2013 Jun; 32(6):1109-15. PubMed ID: 23733986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.